Preclinical evaluation of the preservation of red blood cell concentrates by hypoxic storage technology for transfusion in sickle cell disease

Haematologica. 2022 Aug 1;107(8):1944-1949. doi: 10.3324/haematol.2021.279721.
No abstract available

MeSH terms

  • Anemia, Sickle Cell* / therapy
  • Blood Preservation
  • Blood Transfusion
  • Erythrocytes*
  • Humans
  • Technology

Grants and funding

Funding: This study was supported by Hemanext Inc, the “Etablissement Français du Sang”, the Université Paris Est Créteil (UPEC) and INSERM.